UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) 
November 8, 2012

 

ALLIED HEALTHCARE PRODUCTS, INC.

 

(Exact name of registrant as specified in its charter)

 

Delaware  0-19266  25-1370721 
(State or Other Jurisdiction
of Incorporation)		 (Commission
File Number)		 (IRS Employer
Identification No.)

 

1720 Sublette Avenue, St. Louis, Missouri 
(Address of principal executive offices)		 63110
(Zip Code)

 

Registrant’s telephone number, including area code 
(314) 771-2400 
 
Not applicable 
(Former name or former address, if changed since last report) 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

ITEM 5.07. Submission of Matters to a Vote of Security Holders.

 

The annual meeting of the stockholders of Allied Healthcare Products, Inc. (the “Company”) was held on November 8, 2012. Proxies were solicited pursuant to Regulation 14A of the Securities Exchange Act of 1934. There was no solicitation in opposition to management’s nominees for Directors. The voting results are noted below.

 

ELECTION OF DIRECTORS

 

All nominees for Directors were elected with the following votes cast:

 

  For Withheld Broker Non-Votes
Judith T. Graves 6,313,786 13,549 904,741
Joseph E. Root 6,314,997 12,338 904,741
William A. Peck 6,311,197 16,138 904,741
Earl R. Refsland 6,312,974 14,361 904,741
John D. Weil 6,285,046 42,289 904,741

 

PROPOSAL A

 

Proposal A, concerning the ratification of the appointment of RubinBrown LLP as the Company's independent registered public accounting firm for fiscal 2013 was approved by the stockholders with the following votes cast:

 

For   Against   Abstain   Broker Non-Votes
7,219,721   11,015   1,340   0

 

 
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    ALLIED HEALTHCARE PRODUCTS, INC.
   
  By:
   
Date:  November 9, 2012 /s/  Daniel C. Dunn
        Daniel C. Dunn
        Chief Financial Officer